Literature DB >> 8423873

A novel antineuronal antibody in stiff-man syndrome.

R B Darnell1, J Victor, M Rubin, P Clouston, F Plum.   

Abstract

Two-thirds of stiff-man syndrome (SMS) patients harbor an autoantibody specific for a 64-kD species of glutamic acid decarboxylase (GAD), the rate-limiting enzyme in GABA synthesis. We assayed SMS antisera from two patients with SMS for the presence of anti-GAD antibodies using Western blot, immunohistochemical, and enzymatic analyses. Both SMS antisera recognized an 80-kD antigen present in human and rat neuronal extracts, and failed to recognize the 64-kD GAD species. Immunohistochemistry demonstrated neuronal binding identical to that reported with anti-GAD antibodies. Both sera depleted GAD activity from brain extracts. Our analysis indicates that these SMS antisera differ from previously reported SMS antisera by recognizing a novel 80-kD antigen, and suggests that they contain antibodies directed against either a species of GAD different in size from the 64-kD enzyme, or a protein that co-immunoprecipitates with GAD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423873     DOI: 10.1212/wnl.43.1_part_1.114

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

Review 1.  Stiff man syndrome.

Authors:  H M Meinck
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody.

Authors:  Chandra Mohan Sharma; Rajendra Kumar Pandey; Banshi Lal Kumawat; Dinesh Khandelwal; Pankaj Gandhi
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.